CD8A and neurofibromatosis type 1: Our previous data of a reduced level of terminally differentiated CD8(+)/CD57(+) and CD27(−) T cell fractions in NF1 patients with high benign internal tumor load may indicate a reduced immune capacity already at the benign state, which is further exacerbated by the high PD L1 levels at the malignant state.